+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Pathology Market Size, Share & Trends Analysis Report by Application (Academic Research, Disease Diagnosis), Product (Software, Device), Type, End-use (Diagnostic Labs, Hospitals), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 150 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 4599568
Description Jump to:
The global digital pathology market is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8% from 2024 to 2030. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.

Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth.

For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology.

For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.

Digital Pathology Market Report Highlights

  • Based on product, The device segment held the largest share of 51.72% in 2023 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes a slide management system and scanner. The segment growth is attributed to the increasing adoption of digital pathology in academic research activities with enhanced resolution
  • Based on application, Disease diagnosis is anticipated to witness the fastest growth rate from 2024 to 2030 due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
  • In terms of end-use, The hospitals segment dominated the market in 2023 with a share of 36.7% due to the growing incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
  • North America dominated overall market in 2023 with a share of 40.7%, due to the presence of well-established digital infrastructure and several technological advancements pertaining to the incorporation of technology in healthcare settings

Table of Contents

Chapter 1. Digital Pathology Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database:
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research:
1.3.5. Details Of Primary Research
1.3.5.1. Data for Primary Interviews in North America
1.3.5.2. Data for Primary Interviews in Europe
1.3.5.3. Data for Primary Interviews in APAC
1.3.5.4. Data for Primary Interviews in Latin America
1.3.5.5. Data for Primary Interviews in MEA
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis
1.6.2. Top down market estimation
1.6.3. CAGR Calculation
1.6.4. Key Report Updates
1.7. List of Secondary Sources
1.8. List of Abbreviations
1.9. Report Objectives
1.9.1. Objective - 1
1.9.2. Objective - 2
Chapter 2. Digital Pathology Market: Executive Summary
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Digital Pathology Market: Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. Digital Pathology Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence Of Chronic Diseases
3.2.1.2. Rapid Technological Advancement
3.2.1.2.1. AI integration
3.2.2. Market Restraint Analysis
3.2.2.1. Lack Of Reimbursement For Digital Pathology-Enabled Services
3.2.2.2. Lack of Skilled Professionals
3.2.3. Industry Challenges
3.3. Digital Pathology Market Analysis Tools: Porters
3.4. PESTLE Analysis
3.5. Technology Trend Analysis
3.6. Regulatory Framework
3.7. Cost Structure Analysis
3.8. User Perspective Analysis
3.9. Case Studies
3.10. COVID 19 Impact
Chapter 4. Digital Pathology Market: Product Type Estimates & Trend Analysis
4.1. Digital Pathology Market, Product Type: Key Takeaways
4.2. Digital Pathology Market: Product Type Movement & Market Share Analysis, 2022 & 2030
4.3. Software
4.3.1. Software Market Estimates And Forecasts, 2018-2030 (USD Billion)
4.3.2. Integrated Software
4.3.2.1. Integrated Software Market Estimates And Forecasts, 2018-2030 (USD Billion)
4.3.3. Standalone Software
4.3.3.1. Standalone Software Market Estimates And Forecasts, 2018-2030 (USD Billion)
4.4. Devices
4.4.1. Devices Market Estimates And Forecasts, 2018-2030 (USD Billion)
4.4.2. Scanners
4.4.2.1. Scanners market estimates and forecast, 2018-2030 (USD Million)
4.4.2.2. Brightfield Scanners
4.4.2.2.1. Brightfield Scanners market estimates and forecast, 2018-2030 (USD Million)
4.4.2.3. Fluroscence Scanners
4.4.2.3.1. Fluroscence Scanners market estimates and forecast, 2018-2030 (USD Million)
4.4.2.4. Others
4.4.2.4.1. Others Scanner market estimates and forecast, 2018-2030 (USD Million)
4.4.3. Slide Management System
4.4.3.1. Slide management system market estimates and forecast, 2018-2030 (USD Million)
4.5. Storage Systems
4.5.1. Storage Systems Market Estimates And Forecasts, 2018-2030 (USD Billion)
Chapter 5. Digital Pathology Market: Type Estimates & Trend Analysis
5.1. Digital Pathology Market, by Type: Key Takeaways
5.2. Digital Pathology Market: Type Movement & Market Share Analysis, 2022 & 2030
5.3. Veterinary Pathology
5.3.1. Veterinary Pathology Market Estimates And Forecasts, 2018-2030 (USD Billion)
5.4. Human Pathology
5.4.1. Human Pathology Market Estimates And Forecasts, 2018-2030 (USD Billion)
Chapter 6. Application Estimates & Trend Analysis
6.1. Digital Pathology Market, Application Type: Key Takeaways
6.2. Digital Pathology Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Drug Discovery & Development
6.3.1. Drug Discovery & Development Market Estimates And Forecasts, 2018-2030 (USD Billion)
6.4. Academic Research
6.4.1. Academic Research Market Estimates And Forecasts, 2018-2030 (USD Billion)
6.5. Disease Diagnosis
6.5.1. Disease Diagnosis Market Estimates And Forecasts, 2018-2030 (USD Billion)
6.5.2. Cancer Cell Detection
6.5.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2018-2030 (USD Billion)
6.5.3. Others
6.5.3.1. Others Market Estimates And Forecasts, 2018-2030 (USD Billion)
Chapter 7. Digital Pathology Market: End Use Estimates & Trend Analysis
7.1. Digital Pathology Market, by End Use: Key Takeaways
7.2. Digital Pathology Market: End Use Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4. Biotech & Pharma Companies
7.4.1. Biotech & Pharma Companies Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5. Diagnostics Labs
7.5.1. Diagnostics Labs Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6. Academic & Research Institutes
7.6.1. Academic & Research Institutes Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 8. Digital Pathology Market: Country Estimates & Trend Analysis
8.1 Digital Pathology Market: Regional Movement Analysis, 2022 & 2030
8.1.1 North America
8.1.1.1 North America Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 Key Country Dynamics
8.1.1.2.2 Competitive Scenario
8.1.1.2.3 Regulatory Framework
8.1.1.2.4 Reimbursement Scenario
8.1.1.2.5 U.S. Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Key Country Dynamics
8.1.1.3.2 Competitive Scenario
8.1.1.3.3 Regulatory Framework
8.1.1.3.4 Reimbursement Scenario
8.1.1.3.5 Canada Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.2 UK
8.1.2.2.1 Key Country Dynamics
8.1.2.2.2 Competitive Scenario
8.1.2.2.3 Regulatory Framework
8.1.2.2.4 Reimbursement Scenario
8.1.2.2.5 UK Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Key Country Dynamics
8.1.2.3.2 Competitive Scenario
8.1.2.3.3 Regulatory Framework
8.1.2.3.4 Reimbursement Scenario
8.1.2.3.5 Germany Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 Key Country Dynamics
8.1.2.4.2 Competitive Scenario
8.1.2.4.3 Regulatory Framework
8.1.2.4.4 Reimbursement Scenario
8.1.2.4.5 France Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.5 Italy
8.1.2.5.1 Key Country Dynamics
8.1.2.5.2 Competitive Scenario
8.1.2.5.3 Regulatory Framework
8.1.2.5.4 Reimbursement Scenario
8.1.2.5.5 Italy Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.6 Spain
8.1.2.6.1 Key Country Dynamics
8.1.2.6.2 Competitive Scenario
8.1.2.6.3 Regulatory Framework
8.1.2.6.4 Reimbursement Scenario
8.1.2.6.5 Spain Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.7 Denmark
8.1.2.7.1 Key Country Dynamics
8.1.2.7.2 Competitive Scenario
8.1.2.7.3 Regulatory Framework
8.1.2.7.4 Reimbursement Scenario
8.1.2.7.5 Denmark Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.8 Sweden
8.1.2.8.1 Key Country Dynamics
8.1.2.8.2 Competitive Scenario
8.1.2.8.3 Regulatory Framework
8.1.2.8.4 Reimbursement Scenario
8.1.2.8.5 Sweden Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.2.9 Norway
8.1.2.9.1 Key Country Dynamics
8.1.2.9.2 Competitive Scenario
8.1.2.9.3 Regulatory Framework
8.1.2.9.4 Reimbursement Scenario
8.1.2.9.5 Norway Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.3 Asia-Pacific
8.1.3.1 Asia-Pacific Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Key Country Dynamics
8.1.3.2.2 Competitive Scenario
8.1.3.2.3 Regulatory Framework
8.1.3.2.4 Reimbursement Scenario
8.1.3.2.5 Japan Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.3.3 India
8.1.3.3.1 Key Country Dynamics
8.1.3.3.2 Competitive Scenario
8.1.3.3.3 Regulatory Framework
8.1.3.3.4 Reimbursement Scenario
8.1.3.3.5 India Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.3.4 China
8.1.3.4.1 Key Country Dynamics
8.1.3.4.2 Competitive Scenario
8.1.3.4.3 Regulatory Framework
8.1.3.4.4 Reimbursement Scenario
8.1.3.4.5 China Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Key Country Dynamics
8.1.3.5.2 8. 6. 3.5competitive Scenario
8.1.3.5.3 Regulatory Framework
8.1.3.5.4 Reimbursement Scenario
8.1.3.5.5 Australia Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.3.6 Thailand
8.1.3.6.1 Key Country Dynamics
8.1.3.6.2 Competitive Scenario
8.1.3.6.3 Regulatory Framework
8.1.3.6.4 Reimbursement Scenario
8.1.3.6.5 Thailand Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.3.7 South Korea
8.1.3.7.1 Key Country Dynamics
8.1.3.7.2 Competitive Scenario
8.1.3.7.3 Regulatory Framework
8.1.3.7.4 Reimbursement Scenario
8.1.3.7.5 South Korea Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Key Country Dynamics
8.1.4.2.2 Competitive Scenario
8.1.4.2.3 Regulatory Framework
8.1.4.2.4 Reimbursement Scenario
8.1.4.2.5 Brazil Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Key Country Dynamics
8.1.4.3.2 Competitive Scenario
8.1.4.3.3 Regulatory Framework
8.1.4.3.4 Reimbursement Scenario
8.1.4.3.5 Mexico Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Key Country Dynamics
8.1.4.4.2 Competitive Scenario
8.1.4.4.3 Regulatory Framework
8.1.4.4.4 Reimbursement Scenario
8.1.4.4.5 Argentina Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.5 MEA
8.1.5.1 MEA Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 Key Country Dynamics
8.1.5.2.2 Competitive Scenario
8.1.5.2.3 Regulatory Framework
8.1.5.2.4 Reimbursement Scenario
8.1.5.2.5 South Africa Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Key Country Dynamics
8.1.5.3.2 Competitive Scenario
8.1.5.3.3 Regulatory Framework
8.1.5.3.4 Reimbursement Scenario
8.1.5.3.5 Saudi Arabia Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.5.4 UAE
8.1.5.4.1 Key Country Dynamics
8.1.5.4.2 Competitive Scenario
8.1.5.4.3 Regulatory Framework
8.1.5.4.4 Reimbursement Scenario
8.1.5.4.5 UAE Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
8.1.5.5 Kuwait
8.1.5.5.1 Key Country Dynamics
8.1.5.5.2 Competitive Scenario
8.1.5.5.3 Regulatory Framework
8.1.5.5.4 Reimbursement Scenario
8.1.5.5.5 Kuwait Digital Pathology Market Estimates And Forecast, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Competitive Market Entry Strategies
9.3. Private Companies/ Vendors, by Country/Region
9.4. Company Market Share Analysis, 2023
9.5. Strategy Mapping
9.6. Company Profiles/Listing
9.6.1. Leica Biosystems Nussloch GmbH (Danaher)
9.6.1.1. Overview
9.6.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.1.3. Product Benchmarking
9.6.1.4. Strategic Initiatives
9.6.2. Hamamatsu Photonics, Inc
9.6.2.1. Overview
9.6.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.2.3. Product Benchmarking
9.6.2.4. Strategic Initiatives
9.6.3. Koninklijke Philips N.V.
9.6.3.1. Overview
9.6.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.3.3. Product Benchmarking
9.6.3.4. Strategic Initiatives
9.6.4. Olympus Corporation
9.6.4.1. Overview
9.6.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.4.3. Product Benchmarking
9.6.4.4. Strategic Initiatives
9.6.5. F. Hoffmann-La Roche Ltd
9.6.5.1. Overview
9.6.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.5.3. Product Benchmarking
9.6.5.4. Strategic Initiatives
9.6.6. Mikroscan Technologies, Inc
9.6.6.1. Overview
9.6.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.6.3. Product Benchmarking
9.6.6.4. Strategic Initiatives
9.6.7. Inspirata, Inc.
9.6.7.1. Overview
9.6.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.7.3. Product Benchmarking
9.6.7.4. Strategic Initiatives
9.6.8. Epredia (3DHISTECH Ltd.)
9.6.8.1. Overview
9.6.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.8.3. Product Benchmarking
9.6.8.4. Strategic Initiatives
9.6.9. Visiopharm A/S
9.6.9.1. Overview
9.6.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.9.3. Product Benchmarking
9.6.9.4. Strategic Initiatives
9.6.10. Huron Technologies International Inc.
9.6.10.1. Overview
9.6.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.10.3. Product Benchmarking
9.6.10.4. Strategic Initiatives
9.6.11. ContextVision AB
9.6.11.1. Overview
9.6.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.11.3. Product Benchmarking
9.6.11.4. Strategic Initiatives
9.6.12. CellaVision
9.6.12.1. Overview
9.6.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.12.3. Product Benchmarking
9.6.12.4. Strategic Initiatives
9.6.13. Hangzhou Zhiwei Information Technology Co. Ltd. (Morphogo)
9.6.13.1. Overview
9.6.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.13.3. Product Benchmarking
9.6.13.4. Strategic Initiatives
9.6.14. West Medica Produktions- und Handels- GmbH (West Medica)
9.6.14.1. Overview
9.6.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.14.3. Product Benchmarking
9.6.14.4. Strategic Initiatives
9.6.15. aetherAI
9.6.15.1. Overview
9.6.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.15.3. Product Benchmarking
9.6.15.4. Strategic Initiatives
9.6.16. Ibex (Ibex Medical Analytics)
9.6.16.1. Overview
9.6.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.16.3. Product Benchmarking
9.6.16.4. Strategic Initiatives
9.6.17. SigTuple Technologies Private Limited
9.6.17.1. Overview
9.6.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.17.3. Product Benchmarking
9.6.17.4. Strategic Initiatives
9.6.18. Morphle Labs, Inc
9.6.18.1. Overview
9.6.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.18.3. Product Benchmarking
9.6.18.4. Strategic Initiatives
9.6.19. Bionovation Biotech, Inc
9.6.19.1. Overview
9.6.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.6.19.3. Product Benchmarking
9.6.19.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Digital Pathology Market, By Region, 2018-2030 (USD Million)
Table 4 Global Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 5 Global Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 6 Global Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 7 Global Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 8 North America Digital Pathology Market, By Country, 2018-2030 (USD Million)
Table 9 North America Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 10 North America Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 11 North America Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 12 North America Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 13 U.S. Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 14 U.S. Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 15 U.S. Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 16 U.S. Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 17 Canada Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 18 Canada Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 19 Canada Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 20 Canada Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 21 Europe Digital Pathology Market, By Country, 2018-2030 (USD Million)
Table 22 Europe Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 23 Europe Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 24 Europe Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 25 Europe Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 26 UK Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 27 UK Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 28 UK Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 29 UK Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 30 Germany Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 31 Germany Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 32 Germany Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 33 Germany Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 34 France Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 35 France Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 36 France Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 37 France Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 38 Italy Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 39 Italy Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 40 Italy Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 41 Italy Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 42 Spain Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 43 Spain Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 44 Spain Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 45 Spain Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 46 Denmark Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 47 Denmark Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 48 Denmark Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 49 Denmark Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 50 Norway Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 51 Norway Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 52 Norway Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 53 Norway Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 54 Sweden Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 55 Sweden Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 56 Sweden Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 57 Sweden Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 58 Asia-Pacific Digital Pathology Market, By Country, 2018-2030 (USD Million)
Table 59 Asia-Pacific Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 60 Asia-Pacific Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 61 Asia-Pacific Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 62 Asia-Pacific Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 63 Japan Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 64 Japan Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 65 Japan Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 66 Japan Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 67 China Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 68 China Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 69 China Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 70 China Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 71 India Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 72 India Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 73 India Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 74 India Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 75 South Korea Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 76 South Korea Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 77 South Korea Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 78 South Korea Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 79 Australia Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 80 Australia Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 81 Australia Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 82 Australia Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 83 Thailand Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 84 Thailand Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 85 Thailand Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 86 Thailand Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 87 Latin America Digital Pathology Market, By Country, 2018-2030 (USD Million)
Table 88 Latin America Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 89 Latin America Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 90 Latin America Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 91 Latin America Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 92 Brazil Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 93 Brazil Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 94 Brazil Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 95 Brazil Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 96 Argentina Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 97 Argentina Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 98 Argentina Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 99 Argentina Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 100 Mexico Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 101 Mexico Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 102 Mexico Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 103 Mexico Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 104 Middle East and Africa Digital Pathology Market, By Country, 2018-2030 (USD Million)
Table 105 Middle East and Africa Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 106 Middle East and Africa Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 107 Middle East and Africa Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 108 Middle East and Africa Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 109 South Africa Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 110 South Africa Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 111 South Africa Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 112 South Africa Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 113 Saudi Arabia Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 114 Saudi Arabia Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 115 Saudi Arabia Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 116 Saudi Arabia Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 117 UAE Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 118 UAE Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 119 UAE Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 120 UAE Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
Table 121 Kuwait Digital Pathology Market, By Product, 2018-2030 (USD Million)
Table 122 Kuwait Digital Pathology Market, By Type, 2018-2030 (USD Million)
Table 123 Kuwait Digital Pathology Market, By Application, 2018-2030 (USD Million)
Table 124 Kuwait Digital Pathology Market, By End-Use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Digital Pathology Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s Five Forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Digital pathology market: Product movement analysis
Fig. 17 Digital pathology market: Product segment dashboard
Fig. 18 Digital pathology market product outlook: Key takeaways
Fig. 19 Software market estimates and forecast, 2018-2030 (USD Million)
Fig. 20 Integrated Software market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Standalone Software market estimates and forecast, 2018-2030 (USD Million)
Fig. 22 Device market estimates and forecast, 2018-2030 (USD Million)
Fig. 23 Storage system market estimates and forecast, 2018-2030 (USD Million)
Fig. 24 Digital pathology market: Type movement analysis
Fig. 25 Digital pathology market: Type segment dashboard
Fig. 26 Digital pathology market type outlook: Key takeaways
Fig. 27 Human digital pathology market estimates and forecast, 2018-2030 (USD Million)
Fig. 28 Veterinary digital pathology market estimates and forecast, 2018-2030 (USD Million)
Fig. 29 Digital pathology market: Application movement analysis
Fig. 30 Digital pathology market: Application segment dashboard
Fig. 31 Digital pathology market application outlook: Key takeaways
Fig. 32 Drug discovery & development market estimates and forecast, 2018-2030 (USD Million)
Fig. 33 Academic research market estimates and forecast, 2018-2030 (USD Million)
Fig. 34 Disease diagnosis market estimates and forecast, 2018-2030 (USD Million)
Fig. 35 Digital pathology market: End-use movement analysis
Fig. 36 Digital pathology market: End-use segment dashboard
Fig. 37 Digital pathology market end-use outlook: Key takeaways
Fig. 38 Hospitals market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 Biotech & pharma companies market estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Diagnostic labs market estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Academic &research institutes market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 Regional outlook, 2023 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia-Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America Digital pathology market, 2018-2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. Digital pathology market, 2018-2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada Digital pathology market, 2018-2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe Digital pathology market, 2018-2030 (USD Million)
Fig. 58 UK
Fig. 59 UK Digital pathology market, 2018-2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany Digital pathology market, 2018-2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain Digital pathology market, 2018-2030 (USD Million)
Fig. 64 France
Fig. 65 France Digital pathology market, 2018-2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy Digital pathology market, 2018-2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark Digital pathology market, 2018-2030 (USD Million)
Fig. 70 Norway
Fig. 71 Norway Digital pathology market, 2018-2030 (USD Million)
Fig. 72 Sweden
Fig. 73 Sweden Digital pathology market, 2018-2030 (USD Million)
Fig. 74 Asia-Pacific
Fig. 75 Asia-Pacific Digital pathology market, 2018-2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan Digital pathology market, 2018-2030 (USD Million)
Fig. 78 China
Fig. 79 China Digital Pathology market, 2018-2030 (USD Million)
Fig. 80 India
Fig. 81 India Digital pathology market, 2018-2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea Digital Pathology market, 2018-2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia Digital pathology market, 2018-2030 (USD Million)
Fig. 86 Thailand
Fig. 87 Thailand Digital pathology market, 2018-2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America Digital pathology market, 2018-2030 (USD Million)
Fig. 90 Brazil
Fig. 91 Brazil Digital pathology market, 2018-2030 (USD Million)
Fig. 92 Mexico
Fig. 93 Mexico Digital pathology market, 2018-2030 (USD Million)
Fig. 94 Argentina
Fig. 95 Argentina Digital pathology market, 2018-2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA Digital pathology market, 2018-2030 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa Digital pathology market, 2018-2030 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia Digital pathology market, 2018-2030 (USD Million)
Fig. 102 UAE
Fig. 103 UAE Digital pathology market, 2018-2030 (USD Million)
Fig. 104 Kuwait
Fig. 105 Kuwait Digital pathology market, 2018-2030 (USD Million)

Companies Mentioned

  • Leica Biosystems Nussloch GmbH (Danaher)
  • Hamamatsu Photonics, Inc
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd
  • Mikroscan Technologies, Inc
  • Inspirata, Inc.
  • Epredia (3DHISTECH Ltd.)
  • Visiopharm A/S
  • Huron Technologies International Inc.
  • ContextVision AB
  • CellaVision
  • Hangzhou Zhiwei Information Technology Co. Ltd. (Morphogo)
  • West Medica Produktions- und Handels- GmbH (West Medica)
  • aetherAI
  • Ibex (Ibex Medical Analytics)
  • SigTuple Technologies Private Limited
  • Morphle Labs, Inc
  • Bionovation Biotech, Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.73 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Digital Pathology Market by Product, Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Digital Pathology Market by Product, Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Digital Pathology Market Size, Share & Trends by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Forecast to 2029 - Product Image

Digital Pathology Market Size, Share & Trends by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Forecast to 2029

  • Report
  • 317 Pages
  • Global
From
Digital Pathology Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Digital Pathology Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Digital Pathology Systems - Global Strategic Business Report - Product Image

Digital Pathology Systems - Global Strategic Business Report

  • Report
  • 620 Pages
  • Global
From
Digital Pathology Global Market Report 2024 - Product Image

Digital Pathology Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.